BIOMAT Database Logo BIOMAT Database Logo

Prevalence of antibodies against hepatitis A virus among new immigrants in Israel. 1995

Y V Karetnyi, and E Mendelson, and E Shlyakhov, and E Rubinstein, and N Golubev, and R Levin, and M Sandler, and M Schreiber, and U Rubinstein, and I Shif
Central Virology Laboratory Public Health Services, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

Israel, located in a region endemic for hepatitis A virus (HAV), recently absorbed a large population of immigrants who came from the former USSR. To assess the risk of high morbidity in this population a serosurvey of HAV antibodies was undertaken. Serum samples were collected from 965 new immigrants, of whom 664 came from the European, non-endemic region, and 301 from the Asian and Caucasian endemic regions of the former Soviet Union. They were compared to 240 Israelis. Each population was divided into six age groups: 1-9, 10-19, 20-29, 30-39, 40-49, and 50 years of age and older. The Asian/Caucasian immigrants and the Israeli population were found to share similar characteristics. In both groups, antibodies to HAV (anti-HAV) were present in the 1-9-year-old age group and reached maximum prevalence (90% and 86.7%, respectively) in the 20-29-year-old age group. In contrast, among the European immigrants anti-HAV was first found in the 10-19-year-olds and peaked (93%) in the age group of 50 years and older. It is concluded that immigrants originating from the European part of the former USSR may require vaccination against hepatitis A.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007557 Israel A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. The capital is Jerusalem.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004641 Emigration and Immigration The process of leaving one's country to establish residence in a foreign country. Immigration,Labor Migration,Border Crossing,Chain Migration,Emigration,In-Migration,International Migration,Out-Migration,Return Migration,Settlement and Resettlement,Temporary Migration,Turnaround Migration,Border Crossings,Chain Migrations,Crossing, Border,Crossings, Border,Emigrations,Immigration and Emigration,Immigrations,In Migration,In-Migrations,International Migrations,Labor Migrations,Migration, Chain,Migration, International,Migration, Labor,Migration, Return,Migration, Temporary,Migration, Turnaround,Migrations, Chain,Migrations, International,Migrations, Labor,Migrations, Return,Migrations, Temporary,Migrations, Turnaround,Out Migration,Out-Migrations,Resettlement and Settlement,Return Migrations,Temporary Migrations,Turnaround Migrations
D005260 Female Females
D006506 Hepatitis A INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water. Hepatitis, Infectious,Infectious Hepatitis,Hepatitides, Infectious,Infectious Hepatitides
D006507 Hepatovirus A genus of PICORNAVIRIDAE causing infectious hepatitis naturally in humans and experimentally in other primates. It is transmitted through fecal contamination of food or water. HEPATITIS A VIRUS is the type species. Hepatitis Virus, Infectious,Infectious Hepatitis Virus,Hepatitis Viruses, Infectious,Hepatoviruses,Infectious Hepatitis Viruses

Related Publications

Y V Karetnyi, and E Mendelson, and E Shlyakhov, and E Rubinstein, and N Golubev, and R Levin, and M Sandler, and M Schreiber, and U Rubinstein, and I Shif
Prevalence of hepatitis E virus antibodies, Israel, 2009-2010.
April 2015, Emerging infectious diseases,
Y V Karetnyi, and E Mendelson, and E Shlyakhov, and E Rubinstein, and N Golubev, and R Levin, and M Sandler, and M Schreiber, and U Rubinstein, and I Shif
High prevalence of antibodies against hepatitis A virus among captive nonhuman primates.
April 2010, Primates; journal of primatology,
Y V Karetnyi, and E Mendelson, and E Shlyakhov, and E Rubinstein, and N Golubev, and R Levin, and M Sandler, and M Schreiber, and U Rubinstein, and I Shif
Routine testing for IgG antibodies against hepatitis A virus in Israel.
June 2005, BMC public health,
Y V Karetnyi, and E Mendelson, and E Shlyakhov, and E Rubinstein, and N Golubev, and R Levin, and M Sandler, and M Schreiber, and U Rubinstein, and I Shif
Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany.
December 2013, Medical microbiology and immunology,
Y V Karetnyi, and E Mendelson, and E Shlyakhov, and E Rubinstein, and N Golubev, and R Levin, and M Sandler, and M Schreiber, and U Rubinstein, and I Shif
Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers, and anti-hepatitis C antibodies among immigrants from the former USSR who arrived in Israel during 1990-1991.
January 1999, Infection,
Y V Karetnyi, and E Mendelson, and E Shlyakhov, and E Rubinstein, and N Golubev, and R Levin, and M Sandler, and M Schreiber, and U Rubinstein, and I Shif
Hepatitis B virus infection in Ethiopian immigrants to Israel.
May 1991, Israel journal of medical sciences,
Y V Karetnyi, and E Mendelson, and E Shlyakhov, and E Rubinstein, and N Golubev, and R Levin, and M Sandler, and M Schreiber, and U Rubinstein, and I Shif
Prevalence of dental caries and quality of restorations among new immigrants to Israel.
March 1978, Community dentistry and oral epidemiology,
Y V Karetnyi, and E Mendelson, and E Shlyakhov, and E Rubinstein, and N Golubev, and R Levin, and M Sandler, and M Schreiber, and U Rubinstein, and I Shif
Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003.
May 2006, American journal of infection control,
Y V Karetnyi, and E Mendelson, and E Shlyakhov, and E Rubinstein, and N Golubev, and R Levin, and M Sandler, and M Schreiber, and U Rubinstein, and I Shif
Prevalence of antibodies against hepatitis A virus, hepatitis B virus, and Treponema pallidum in Mauritius.
January 1991, Scandinavian journal of infectious diseases,
Y V Karetnyi, and E Mendelson, and E Shlyakhov, and E Rubinstein, and N Golubev, and R Levin, and M Sandler, and M Schreiber, and U Rubinstein, and I Shif
Prevalence of antibodies against hepatitis C virus in a dialysis unit.
January 1992, Nephron,
Copied contents to your clipboard!